Search

Your search keyword '"Hermann Toplak"' showing total 169 results

Search Constraints

Start Over You searched for: Author "Hermann Toplak" Remove constraint Author: "Hermann Toplak"
169 results on '"Hermann Toplak"'

Search Results

1. Treatment gaps in the implementation of LDL cholesterol control among high- and very high-risk patients in Europe between 2020 and 2021: the multinational observational SANTORINI studyResearch in context

2. Association of branched-chain amino acids with mortality-the Ludwigshafen Risk and Cardiovascular Health (LURIC) study

3. Measuring subcutaneous fat thickness using skinfold calipers vs. high-resolution B-scan ultrasonography in healthy volunteers: A pilot study

4. Evaluation of contemporary treatment of high- and very high-risk patients for the prevention of cardiovascular events in Europe – Methodology and rationale for the multinational observational SANTORINI study

5. Underestimation of resting metabolic rate using equations compared to indirect calorimetry in normal-weight subjects: Consideration of resting metabolic rate as a function of body composition

6. The ABCD of Obesity: An EASO Position Statement on a Diagnostic Term with Clinical and Scientific Implications

7. European Practical and Patient-Centred Guidelines for Adult Obesity Management in Primary Care

8. Short-Term Treatment with Alirocumab, Flow-Dependent Dilatation of the Brachial Artery and Use of Magnetic Resonance Diffusion Tensor Imaging to Evaluate Vascular Structure: An Exploratory Pilot Study

9. Effects of Alirocumab on Triglyceride Metabolism: A Fat-Tolerance Test and Nuclear Magnetic Resonance Spectroscopy Study

10. Sarcopenic Obesity: Time to Meet the Challenge

11. Practical Recommendations of the Obesity Management Task Force of the European Association for the Study of Obesity for the Post-Bariatric Surgery Medical Management

12. Obesity and Type 2 Diabetes: Two Diseases with a Need for Combined Treatment Strategies - EASO Can Lead the Way

13. A Proposal of the European Association for the Study of Obesity to Improve the ICD-11 Diagnostic Criteria for Obesity Based on the Three Dimensions Etiology, Degree of Adiposity and Health Risk

15. European Guidelines for Obesity Management in Adults

19. An EASO Position Statement on Multidisciplinary Obesity Management in Adults

21. Diabetes mellitus and co-morbid depression: treatment with milnacipran results in significant improvement of both diseases (results from the Austrian MDDM study group)

23. Antihyperglykämische Therapie bei Diabetes mellitus Typ 2 (Update 2023)

24. Psychische und neurokognitive Erkrankungen und Diabetes mellitus (Update 2023)

25. Nutrition for diabetic patients (Update 2023)

26. Obesity and type 2 diabetes (Update 2023)

27. Evaluation of lipoprotein(a) in the prevention and management of atherosclerotic cardiovascular disease: A survey among the Lipid Clinics Network

28. Reproductive outcomes after bariatric surgery in women

29. Evaluation of contemporary treatment of high- and very high-risk patients for the prevention of cardiovascular events in Europe – Methodology and rationale for the multinational observational SANTORINI study

30. High-Protein, Low-Glycaemic Meal Replacement Improves Physical Health-Related Quality of Life in High-Risk Persons for Metabolic Syndrome—A Subanalysis of the Randomised-Controlled ACOORH Trial

31. A High‐Protein and Low‐Glycemic Formula Diet Improves Blood Pressure and Other Hemodynamic Parameters in High‐Risk Individuals

32. Contemporary Treatment Gaps in the Implementation of Ldl Cholesterol Control Among High- And Very High-Risk Patients in Europe between 2020–2021 – The Multinational Santorini Study

34. Antihyperglykämische Therapie bei Diabetes mellitus Typ 2 (Update 2019)

35. Psychische Erkrankungen und Diabetes mellitus (Update 2019)

36. Ernährungsempfehlungen bei Diabetes mellitus (Update 2019)

37. Insulintherapie bei Typ 2 Diabetes mellitus (Update 2019)

38. 'Diabesity' – Adipositas und Typ-2-Diabetes (Update 2019)

39. High-protein, low-glycaemic meal replacement decreases fasting insulin and inflammation markers — a 12-month subanalysis of the ACOORH trial

40. Effects of a Protein-Rich, Low-Glycaemic Meal Replacement on Changes in Dietary Intake and Body Weight Following a Weight-Management Intervention—The ACOORH Trial

41. Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

42. Prediabetes Conversion to Normoglycemia is Superior Adding a Low-Carbohydrate and Energy Deficit Formula Diet to Lifestyle Intervention—A 12-Month Subanalysis of the ACOORH Trial

43. Meal replacement by formula diet reduces weight more than a lifestyle intervention alone in patients with overweight or obesity and accompanied cardiovascular risk factors-the ACOORH trial

44. Efficacy and tolerability of alirocumab in Austrian clinical practice – results of the non-interventional PEARL-AT study

45. Obesity and cardiovascular risk

46. Lipide: Diagnostik und Therapie bei Diabetes mellitus (Update 2019)

47. Clinical-Pathological Conference Series from the Medical University of Graz

48. A Proposal of the European Association for the Study of Obesity to Improve the ICD-11 Diagnostic Criteria for Obesity Based on the Three Dimensions Etiology, Degree of Adiposity and Health Risk

49. Was sind Barrieren der Ernährungstherapie bei mangelernährten, hospitalisierten Patienten der Inneren Medizin?

50. Obesity and Type 2 Diabetes: Two Diseases with a Need for Combined Treatment Strategies - EASO Can Lead the Way

Catalog

Books, media, physical & digital resources